{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:51:35Z","timestamp":1771307495086,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1124\/jpet.117.244434","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T01:10:20Z","timestamp":1507857020000},"page":"77-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["The Anti\u2013Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo"],"prefix":"10.1016","volume":"364","author":[{"given":"Maria Grazia","family":"Atzori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucio","family":"Tentori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Ruffini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Ceci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Scimeca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Miguel","family":"Lacal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Graziani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.117.244434_bib1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13046-017-0577-2","article-title":"The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells","volume":"36","author":"Atzori","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1124\/jpet.117.244434_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/neuonc\/nov288","article-title":"Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas","volume":"18","author":"Baumgarten","year":"2016","journal-title":"Neuro-oncol"},{"key":"10.1124\/jpet.117.244434_bib3","doi-asserted-by":"crossref","first-page":"e00010","DOI":"10.1002\/prp2.10","article-title":"Antitumor activity of (R,R\u2032)-4-methoxy-1-naphthylfenoterol in a rat C6 glioma xenograft model in the mouse","volume":"1","author":"Bernier","year":"2013","journal-title":"Pharmacol Res Perspect"},{"key":"10.1124\/jpet.117.244434_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.259re1","article-title":"Positive and negative modulation of angiogenesis by VEGFR1 ligands","volume":"2","author":"Cao","year":"2009","journal-title":"Sci Signal"},{"key":"10.1124\/jpet.117.244434_bib5","doi-asserted-by":"crossref","first-page":"10382","DOI":"10.1074\/jbc.M313237200","article-title":"The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1","volume":"279","author":"Christinger","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.117.244434_bib6","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1074\/jbc.273.6.3216","article-title":"Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor\/placenta growth factor receptor Flt-1 required for binding and structural stability","volume":"273","author":"Davis-Smyth","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.117.244434_bib7","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1517\/14728222.2014.948420","article-title":"Placental growth factor in cancer","volume":"18","author":"Dewerchin","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"10.1124\/jpet.117.244434_bib8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11060-017-2477-x","article-title":"The role of bevacizumab in the treatment of glioblastoma","volume":"133","author":"Diaz","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1124\/jpet.117.244434_bib9","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/neuonc\/now113","article-title":"EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation","volume":"18","author":"Eskilsson","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1124\/jpet.117.244434_bib10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"10.1124\/jpet.117.244434_bib11","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nrc2524","article-title":"FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?","volume":"8","author":"Fischer","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/jpet.117.244434_bib12","doi-asserted-by":"crossref","first-page":"72868","DOI":"10.18632\/oncotarget.12108","article-title":"Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding","volume":"7","author":"Graziani","year":"2016","journal-title":"Oncotarget"},{"key":"10.1124\/jpet.117.244434_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00441-002-0651-7","article-title":"Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion","volume":"310","author":"Grobben","year":"2002","journal-title":"Cell Tissue Res"},{"key":"10.1124\/jpet.117.244434_bib14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ijc.20260","article-title":"Inhibition of solid tumor growth by gene transfer of VEGF receptor-1 mutants","volume":"111","author":"Heidenreich","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1124\/jpet.117.244434_bib15","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1586\/era.09.68","article-title":"Biological mechanisms of bevacizumab-associated adverse events","volume":"9","author":"Higa","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1124\/jpet.117.244434_bib16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/14737140.2017.1322903","article-title":"Angiogenesis inhibitors in tackling recurrent glioblastoma","volume":"17","author":"Hundsberger","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1124\/jpet.117.244434_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/bbrc.1998.8578","article-title":"Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2","volume":"246","author":"Igarashi","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.117.244434_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3858\/emm.2012.44.1.023","article-title":"Role of placenta growth factor in cancer and inflammation","volume":"44","author":"Kim","year":"2012","journal-title":"Exp Mol Med"},{"key":"10.1124\/jpet.117.244434_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/BJ20110301","article-title":"Signal transduction by vascular endothelial growth factor receptors","volume":"437","author":"Koch","year":"2011","journal-title":"Biochem J"},{"key":"10.1124\/jpet.117.244434_bib20","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.ejca.2008.06.032","article-title":"Inhibition of endothelial cell migration and angiogenesis by a vascular endothelial growth factor receptor-1 derived peptide","volume":"44","author":"Lacal","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1124\/jpet.117.244434_bib21","first-page":"1399","article-title":"Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A","volume":"9","author":"Lamszus","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.117.244434_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10517-012-1612-0","article-title":"Ligand-receptor assay for evaluation of functional activity of human recombinant VEGF and VEGFR-1 extracellular fragment","volume":"152","author":"Leopol\u2019d","year":"2012","journal-title":"Bull Exp Biol Med"},{"key":"10.1124\/jpet.117.244434_bib23","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4161\/cbt.12.10.17672","article-title":"Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC)","volume":"12","author":"Li","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"10.1124\/jpet.117.244434_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1749-6632.2002.tb04870.x","article-title":"Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders","volume":"979","author":"Luttun","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.117.244434_bib25","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1242\/jcs.00673","article-title":"Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin","volume":"116","author":"Orecchia","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1124\/jpet.117.244434_bib26","first-page":"5822","article-title":"Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis","volume":"53","author":"Plate","year":"1993","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.117.244434_bib27","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1084\/jem.20141555","article-title":"FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis","volume":"212","author":"Qian","year":"2015","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.117.244434_bib28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbrc.2008.07.121","article-title":"VEGF receptor protein-tyrosine kinases: structure and regulation","volume":"375","author":"Roskoski","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"4 Suppl","key":"10.1124\/jpet.117.244434_bib29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/cncr.24789","article-title":"Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1 (human antibody targeting vascular endothelial growth factor receptor-1)","volume":"116","author":"Schwartz","year":"2010","journal-title":"Cancer"},{"key":"10.1124\/jpet.117.244434_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10456-006-9055-8","article-title":"Vascular endothelial growth factor receptor-1 (VEGFR-1\/Flt-1): a dual regulator for angiogenesis","volume":"9","author":"Shibuya","year":"2006","journal-title":"Angiogenesis"},{"key":"10.1124\/jpet.117.244434_bib31","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/1947601911423031","article-title":"Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies","volume":"2","author":"Shibuya","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1124\/jpet.117.244434_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/B:NEON.0000013495.08168.8f","article-title":"Autocrine pathways of the vascular endothelial growth factor (VEGF) in glioblastoma multiforme: clinical relevance of radiation-induced increase of VEGF levels","volume":"66","author":"Steiner","year":"2004","journal-title":"J Neurooncol"},{"key":"10.1124\/jpet.117.244434_bib34","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.117.244434_bib35","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/neuonc\/now043","article-title":"Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo","volume":"18","author":"Szabo","year":"2016","journal-title":"Neuro-oncol"},{"key":"10.1124\/jpet.117.244434_bib36","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1248\/bpb.34.1785","article-title":"Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy","volume":"34","author":"Takahashi","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/jpet.117.244434_bib37","first-page":"5370","article-title":"Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma","volume":"9","author":"Tentori","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.117.244434_bib38","first-page":"525","article-title":"Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs","volume":"27","author":"Tentori","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1124\/jpet.117.244434_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jocn.2017.06.070","article-title":"Clinical outcomes in recurrent glioblastoma with bevacizumab therapy: an analysis of the literature","volume":"44","author":"Tipping","year":"2017","journal-title":"J Clin Neurosci"},{"key":"10.1124\/jpet.117.244434_bib40","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.expneurol.2004.08.015","article-title":"Spontaneous regression of experimental gliomas--an immunohistochemical and MRI study of the C6 glioma spheroid implantation model","volume":"190","author":"Vince","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1124\/jpet.117.244434_bib41","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1158\/1078-0432.CCR-06-0831","article-title":"Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer","volume":"12","author":"Wu","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.117.244434_bib42","first-page":"465","article-title":"Antitumor effect of endostatin overexpressed in C6 glioma cells is associated with the down-regulation of VEGF","volume":"38","author":"Yang","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1124\/jpet.117.244434_bib43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/bj3580465","article-title":"Direct identification of a major autophosphorylation site on vascular endothelial growth factor receptor Flt-1 that mediates phosphatidylinositol 3\u2032-kinase binding","volume":"358","author":"Yu","year":"2001","journal-title":"Biochem J"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524261310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524261310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.117.244434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:56:58Z","timestamp":1739995018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524261310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0022356524261310"],"URL":"https:\/\/doi.org\/10.1124\/jpet.117.244434","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Anti\u2013Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.117.244434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}